microcirculationРегионарное кровообращение и микроциркуляцияRegional blood circulation and microcirculation1682-66552712-9756Academician I.P. Pavlov First St. Petersburg State Medical University10.24884/1682-6655-2020-19-3-19-24microcirculation-844Research ArticleОРИГИНАЛЬНЫЕ СТАТЬИ (КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ)ORIGINAL ARTICLES (CLINICAL INVESTIGATIONS)Прижизненное изучение направления оттока лимфы при раке легкого с помощью индоцианина зеленогоIntravital study of lymphatic drainage in lung cancer using indocyanine greenАкоповА. Л.AkopovA. L.

Акопов Андрей Леонидович – д-р мед. наук, профессор, руководитель отдела торакальной хирургии НИИ хирургии и неотложной медицины

197022, Санкт-Петербург, ул. Льва Толстого, д. 6-8

Akopov Andrey L. – MD, professor, Head of the Department of thoracic surgery, Research Institute for Surgery and Emergency Medicine

6-8 L’va Tolstogo street, Saint Petersburg, 197022

Akopovand@mail.ruПапаянГ. В.PapayanG. V.

Папаян Гарри Вазгенович – канд. техн. наук, старший научный сотрудник центра лазерной медицины ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет им. акад. И. П. Павлова» МЗ РФ, старший научный сотрудник НИЛ микроциркуляции ФГБУ «Национальный медицинский исследовательский центр им. В. А. Алмазова» Минздрава России

197022, Санкт-Петербург, ул. Льва Толстого, д. 6-8

Papayan Garry V. – PhD, Pavlov University, Almazov National Medical Research Centre

6-8 L’va Tolstogo street, Saint Petersburg, 197022

pgarry@mail.ruИльинА. А.IlinA. A.

Ильин Андрей Андреевич – врач – торакальный хирург онкологического отделения №4 (торакальной хирургии) НИИ хирургии и неотложной медицины

197022, Санкт-Петербург, ул. Льва Толстого, д. 6-8

Ilin Andrey A. – Department of thoracic surgery, Research Institute for Surgery and Emergency Medicine

6-8 L’va Tolstogo street, Saint Petersburg, 197022

Andrewilyin@icloud.comФедеральное государственное бюджетное образовательное учреждение высшего образования «Первый Санкт-Петербургский государственный медицинский университет имени академика И. П. Павлова» Министерства здравоохранения Российской ФедерацииРоссияPavlov UniversityRussian Federation2020071020201931924Copyright © Акопов А.Л., Папаян Г.В., Ильин А.А., 20202020Акопов А.Л., Папаян Г.В., Ильин А.А.Akopov A.L., Papayan G.V., Ilin A.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.microcirc.ru/jour/article/view/844лимфооттоклимфатические узлыинфракрасная флуоресцентная визуализацияиндоцианин зеленыйрак легкогоlymph flowlymph nodesinfrared fluorescenceindocyanine greenlung cancerReferencesDe Leyn P, Lardinois D, Van Schil P et al. European Trends in Preoperative and Intraoperative Nodal Staging: ESTS Guidelines. Journal of Thoracic Oncology. 2007;2(4):357–361. Doi: 10.1097/01.jto.0000263722.22686.1c.De Leyn P, Lardinois D, Van Schil P et al. European Trends in Preoperative and Intraoperative Nodal Staging: ESTS Guidelines. Journal of Thoracic Oncology. 2007;2(4):357–361. Doi: 10.1097/01.jto.0000263722.22686.1c.Ndiaye A, Dimarino V, Ndiaye A, Gaye M, Ba PS, Nazarian S. Variations in lung lymphatic drainage into the inferior tracheobronchial lymph nodes junction: Applications in lung cancer. Clin Anat. 2016;29(7):955–962. Doi: 10.1002/ca.22751.Ndiaye A, Dimarino V, Ndiaye A, Gaye M, Ba PS, Nazarian S. Variations in lung lymphatic drainage into the inferior tracheobronchial lymph nodes junction: Applications in lung cancer. Clin Anat. 2016;29(7):955–962. Doi: 10.1002/ca.22751.Topol M, Masłoń A. The problem of direct lymph drainage of the bronchopulmonary segments into the mediastinal and hilar lymph nodes. Clin Anat. 2009;22(4):509–516. Doi: 10.1002/ca.20790.Topol M, Masłoń A. The problem of direct lymph drainage of the bronchopulmonary segments into the mediastinal and hilar lymph nodes. Clin Anat. 2009;22(4):509–516. Doi: 10.1002/ca.20790.Sevick-Muraca EM, Kwon S, Rasmussen JC. Emerging lymphatic imaging technologies for mouse and man. J. Clinic. Invest. 2014;124(3):905–914. Doi:10.1172/JCI71612.Sevick-Muraca EM, Kwon S, Rasmussen JC. Emerging lymphatic imaging technologies for mouse and man. J. Clinic. Invest. 2014;124(3):905–914. Doi:10.1172/JCI71612.Bollinger A, Amann-Vesti BR. Fluorescence microlymphography: diagnostic potential in lymphedema and basis for the measurement of lymphatic pressure and flow velocity. Lymphology. 2007;40(2):52–62.Bollinger A, Amann-Vesti BR. Fluorescence microlymphography: diagnostic potential in lymphedema and basis for the measurement of lymphatic pressure and flow velocity. Lymphology. 2007;40(2):52–62.Alander JT, Kaartinen I, Laakso A et al. Review of Indocyanine Green Fluorescent Imaging in Surgery. Inter. J. Biomed. Imaging. 2012;(1):940585. Doi:10.1155/2012/940585.Alander JT, Kaartinen I, Laakso A et al. Review of Indocyanine Green Fluorescent Imaging in Surgery. Inter. J. Biomed. Imaging. 2012;(1):940585. Doi:10.1155/2012/940585.Papayan G, Akopov A. Potentials of Indocyanine Green Near-Infrared Fluorescence Imaging in Experimental and Clinical Practice. Photodiagnosis and Photodynamic Therapy. 2018;24:292–299. Doi: 10.1016/j.pdpdt.2018.10.011.Papayan G, Akopov A. Potentials of Indocyanine Green Near-Infrared Fluorescence Imaging in Experimental and Clinical Practice. Photodiagnosis and Photodynamic Therapy. 2018;24:292–299. Doi: 10.1016/j.pdpdt.2018.10.011.Папаян Г. В, Чефу С. Г., Петрищев Н. Н. и др. Возможность использования конъюгата индоцианина зеленого с альбумином для инфракрасной флуоресцентной диагностики патологических процессов в эксперименте // Вопросы онкологии. – 2016. – Т. 6. – С. 839–844.Papayan GV, Chefu SG, Petrishchev NN, Ilin AA, Akopov AL. Vozmozhnost ispolzovanya konyugata indocianina zelenogo s albuminom dlya infrakrasnoi fluorscentnoi diagnostiki patologicheskich processov v eksperimente. Voprosi onkologii. 2016;6:839–844. (In Russ.).Rusch VW, Asamura H, Watanabe H, Giroux DJ, RamiPorta R, Goldstraw P. The IASLC Lung Cancer Staging Project: A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer. Journal of Thoracic Oncology. Elsevier BV. 2009;4(5):568–577. Doi: 10.1097/jto.0b013e3181a0d82e.Rusch VW, Asamura H, Watanabe H, Giroux DJ, RamiPorta R, Goldstraw P. The IASLC Lung Cancer Staging Project: A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer. Journal of Thoracic Oncology. Elsevier BV. 2009;4(5):568–577. Doi: 10.1097/jto.0b013e3181a0d82e.Takahashi K, Stanford W, Van Beek E, Thompson B, Mullan B, Sato Y. Mediastinal lymphatic drainage from pulmonary lobe based on CT observations of histoplasmosis: implications for minimal N2 disease of non-small-cell lung cancer. Radiat Med. 2007;25:393–401. Doi: 10.1007/s11604007-0156-0.Takahashi K, Stanford W, Van Beek E, Thompson B, Mullan B, Sato Y. Mediastinal lymphatic drainage from pulmonary lobe based on CT observations of histoplasmosis: implications for minimal N2 disease of non-small-cell lung cancer. Radiat Med. 2007;25:393–401. Doi: 10.1007/s11604007-0156-0.Asamura H, Nakayama H, Kondo H et al. Lobe-specific extent of systematic lymph node dissection for non-small cell lung carcinomas according to a retrospective study of metastasis and prognosis. J Thorac Cardiovasc Surg. 1999; 117(6):1102–1111.Asamura H, Nakayama H, Kondo H et al. Lobe-specific extent of systematic lymph node dissection for non-small cell lung carcinomas according to a retrospective study of metastasis and prognosis. J Thorac Cardiovasc Surg. 1999; 117(6):1102–1111.Hishida T, Saji H, Watanabe SI et al. A randomized phase III trial of lobe-specific vs. systematic nodal dissection for clinical stage I-II non-small cell lung cancer (JCOG1413). Jpn J Clin Oncol. 2018;48(2):190–194. Doi: 10.1093/jjco/hyx170.Hishida T, Saji H, Watanabe SI et al. A randomized phase III trial of lobe-specific vs. systematic nodal dissection for clinical stage I-II non-small cell lung cancer (JCOG1413). Jpn J Clin Oncol. 2018;48(2):190–194. Doi: 10.1093/jjco/hyx170.Riquet M, Rivera C, Pricopi C et al. Is the lymphatic drainage of lung cancer lobe-specific? A surgical appraisal. Eur J Cardiothorac Surg. 2015;47(3):543–549. Doi: 10.1093/ejcts/ezu226.Riquet M, Rivera C, Pricopi C et al. Is the lymphatic drainage of lung cancer lobe-specific? A surgical appraisal. Eur J Cardiothorac Surg. 2015;47(3):543–549. Doi: 10.1093/ejcts/ezu226.Bille A, Woo KM, Ahmad U et al. Incidence of occult pN2 disease following resection and mediastinal lymph node dissection in clinical stage I lung cancer patients. Eur J Cardiothorac Surg. 2017;51(4):674–679. Doi: 10.1093/ejcts/ezw400.Bille A, Woo KM, Ahmad U et al. Incidence of occult pN2 disease following resection and mediastinal lymph node dissection in clinical stage I lung cancer patients. Eur J Cardiothorac Surg. 2017;51(4):674–679. Doi: 10.1093/ejcts/ezw400.Han H, Chen H. Selective lymph node dissection in early-stage non-small cell lung cancer. J Thorac Dis. 2017; 9(7):2102–2107. Doi: 10.21037/jtd.2017.06.04.Han H, Chen H. Selective lymph node dissection in early-stage non-small cell lung cancer. J Thorac Dis. 2017; 9(7):2102–2107. Doi: 10.21037/jtd.2017.06.04.Fang L, Xu J, Ye B, Yu G, Chen G, Yang J. Is lobe specific lymph node dissection adequate for cN0–1 non-small cell lung cancer? Journal of Cardiothoracic Surgery. 2020;15:46. Doi: 10.1186/s13019-020-1087-4.Fang L, Xu J, Ye B, Yu G, Chen G, Yang J. Is lobe specific lymph node dissection adequate for cN0–1 non-small cell lung cancer? Journal of Cardiothoracic Surgery. 2020;15:46. Doi: 10.1186/s13019-020-1087-4.Meacci E, Nachira D, Chiappetta M, Congedo MT, Petracca-Ciavarella L, Ferretti G, Margaritora S. Editorial on Long-term outcomes after near-infrared sentinel lymph node mapping in non–small cell lung cancer. Journal of thoracic disease. 2018;10(33):3922–3926. Doi: 10.21037/jtd.2018.09.19.Meacci E, Nachira D, Chiappetta M, Congedo MT, Petracca-Ciavarella L, Ferretti G, Margaritora S. Editorial on Long-term outcomes after near-infrared sentinel lymph node mapping in non–small cell lung cancer. Journal of thoracic disease. 2018;10(33):3922–3926. Doi: 10.21037/jtd.2018.09.19.

The authors declare that there are no conflicts of interest present.